Drug intelligence / Profile preview

Calirend

Development stage: Unknown
Lead developer: Rockwell Medical

Overview

Calirend is a hemodialysis product supplied by Rockwell Medical, primarily used in the treatment of patients with chronic kidney disease. As a hemodialysis concentrate or dialysate, its function is to remove toxins and balance electrolytes in the patient's bloodstream during hemodialysis, a process vital for sustaining life when kidneys are no longer able to perform this function.

Brand names: Calirend

Beyond the preview

Go deeper on Calirend.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Calirend.

Explore the full profile